Who owns DR REDDYS LABORATORIES LTD?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of RDY from SEC Form 13F filings across 233 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-09-30 reporting period, 233 institutions disclosed 128.4M shares of DR REDDYS LABORATORIES LTD worth $1.63B — about 15.4% of shares outstanding; the largest disclosed holder is MORGAN STANLEY. Source: SEC Form 13F filings, parsed by EvidInvest.
233
13F holders
$1.63B
value, 2026 filers
15.4%
of shares outstanding (128.4M sh)
28
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of RDY's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | MORGAN STANLEY | 24.3M | $306.6M | 0.0% | 2.9% | +122.1% |
| 2 | BlackRock, Inc. | 9.2M | $115.7M | 0.0% | 1.1% | -13.4% |
| 3 | Aikya Investment Management Ltd | 9.1M | $114.4M | 33.9% | 1.1% | +6.8% |
| 4 | ROYAL BANK OF CANADA | 8.7M | $109.7M | 0.0% | 1% | -5.6% |
| 5 | Robeco Institutional Asset Management B.V. | 8.7M | $109.6M | 0.1% | 1% | -51.8% |
| 6 | RENAISSANCE TECHNOLOGIES LLC | 7.0M | $88.1M | 0.1% | 0.8% | -5.0% |
| 7 | FRANKLIN TEMPLETON INC | 6.4M | $94.5M | 0.0% | 0.8% | +124.9% |
| 8 | DIMENSIONAL FUND ADVISORS LP | 5.2M | $66.0M | 0.0% | 0.6% | -1.7% |
| 9 | JPMORGAN CHASE & CO | 4.5M | $57.4M | 0.0% | 0.5% | +9.7% |
| 10 | ALLIANCEBERNSTEIN L.P. | 3.8M | $47.7M | 0.0% | 0.5% | +1.3% |
| 11 | STATE STREET CORP | 3.7M | $47.2M | 0.0% | 0.4% | -9.4% |
| 12 | VANGUARD CAPITAL MANAGEMENT LLC | 3.1M | $39.1M | 0.0% | 0.4% | 0.0% |
| 13 | MILLENNIUM MANAGEMENT LLC | 2.8M | $35.2M | 0.0% | 0.3% | +495.2% |
| 14 | BNP PARIBAS FINANCIAL MARKETS | 2.6M | $33.4M | 0.0% | 0.3% | -0.3% |
| 15 | SCHRODER INVESTMENT MANAGEMENT GROUP | 2.5M | $32.0M | 0.0% | 0.3% | +54.1% |
| 16 | ACADIAN ASSET MANAGEMENT LLC | 2.0M | $24.9M | 0.0% | 0.2% | -12.7% |
| 17 | AMERICAN CENTURY COMPANIES INC | 1.9M | $24.3M | 0.0% | 0.2% | +5.1% |
| 18 | GOLDMAN SACHS GROUP INC | 1.6M | $20.6M | 0.0% | 0.2% | +54.8% |
| 19 | VANGUARD PORTFOLIO MANAGEMENT LLC | 1.4M | $17.3M | 0.0% | 0.2% | -10.1% |
| 20 | Creative Planning | 1.3M | $16.6M | 0.0% | 0.2% | +5.7% |
| 21 | UBS Group AG | 1.1M | $14.4M | 0.0% | 0.1% | -31.0% |
| 22 | CITADEL ADVISORS LLC | 1.1M | $14.2M | 0.0% | 0.1% | +1317.7% |
| 23 | BESSEMER GROUP INC | 987,773 | $12.5M | 0.0% | 0.1% | -46.8% |
| 24 | Schonfeld Strategic Advisors LLCNEW | 857,728 | $10.8M | 0.0% | 0.1% | new |
| 25 | Quantinno Capital Management LP | 745,411 | $9.4M | 0.0% | 0.1% | +16.0% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.